This congress serves as a pivotal platform to explore the latest advancements and emerging trends in both cellular and humoral immunotherapies, particularly in their application to autoimmune diseases. The congress focuses on bridging the gap between treatments for hematological malignancies and autoimmune disorders, recognizing the profound overlap and unique challenges within these fields. Participants will hear from leading experts, researchers, and clinicians who are at the forefront of developing new therapies and treatment strategies. With a combination of cutting-edge research presentations and engaging interactions, the organizers aim to foster meaningful discussions about the most recent innovations, challenges, and breakthroughs in immunotherapy. Comprehensive program features renowned speakers, each sharing their expertise on topics ranging from immune system modulation to the clinical applications of CAR T-cell therapy, T cell engagers, and B-cell lineage targeting in autoimmunity. These discussions will deepen the understanding and broaden the potential for more effective, personalized treatments.